Low Expression of GOT2 Promotes Tumor Progress and Predicts Poor Prognosis in Hepatocellular Carcinoma

References

• Sung H , Ferlay J , Siegel RL et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209–249 (2021).
   PubMed Web of Science ®Google Scholar
• Siegel RL , Miller KD , Jemal A . Cancer statistics, 2018. CA Cancer J. Clin. 68(1), 7–30 (2018).
   PubMed Web of Science ®Google Scholar
• Bray F , Ferlay J , Soerjomataram I , Siegel RL , Torre LA , Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68(6), 394–424 (2018).
   PubMed Web of Science ®Google Scholar
• Park JW , Chen M , Colombo M et al. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. Liver Int. 35(9), 2155–2166 (2015).
   PubMed Web of Science ®Google Scholar
• Wang CY , Li S . Clinical characteristics and prognosis of 2887 patients with hepatocellular carcinoma: a single center 14 years experience from China. Medicine (Baltimore) 98(4), e14070 (2019).
   PubMed Web of Science ®Google Scholar
• Wang XK , Liao XW , Yang CK et al. Oncogene PLCE1 may be a diagnostic biomarker and prognostic biomarker by influencing cell cycle, proliferation, migration, and invasion ability in hepatocellular carcinoma cell lines. J. Cell. Physiol. 235(10), 7003–7017 (2020).
   PubMed Web of Science ®Google Scholar
• Jiang Y , Yao B , Chen T et al. BICD1 functions as a prognostic biomarker and promotes hepatocellular carcinoma progression. Pathol. Res. Pract. 216(4), 152858 (2020).
   PubMed Web of Science ®Google Scholar
• Chen DH , Wu QW , Li XD , Wang SJ , Zhang ZM . SYPL1 overexpression predicts poor prognosis of hepatocellular carcinoma and associates with epithelial–mesenchymal transition. Oncol. Rep. 38(3), 1533–1542 (2017).
   PubMed Web of Science ®Google Scholar
• Liang R , Lin Y , Ye JZ et al. High expression of RBM8A predicts poor patient prognosis and promotes tumor progression in hepatocellular carcinoma. Oncol. Rep. 37(4), 2167–2176 (2017).
   PubMed Web of Science ®Google Scholar
• Tang B , Liang X , Tang F et al. Expression of USP22 and survivin is an indicator of malignant behavior in hepatocellular carcinoma. Int. J. Oncol. 47(6), 2208–2216 (2015).
   PubMed Web of Science ®Google Scholar
• Fagerberg L , Hallstrom BM , Oksvold P et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol. Cell Proteomics 13(2), 397–406 (2014).
   PubMed Web of Science ®Google Scholar
• Liu M , Liu X , Liu S et al. Big data-based identification of multi-gene prognostic signatures in liver cancer. Front. Oncol. 10, 847 (2020).
   PubMedGoogle Scholar
• Kim KH , Lee MS . Autophagy – a key player in cellular and body metabolism. Nat. Rev. Endocrinol. 10(6), 322–337 (2014).
   PubMed Web of Science ®Google Scholar
• Wang H , Liu Y , Wang D et al. The upstream pathway of mTOR-mediated autophagy in liver diseases. Cells 8(12), 1597 (2019).
   PubMed Web of Science ®Google Scholar
• Fujimoto A , Furuta M , Totoki Y et al. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer. Nat. Genet. 48(5), 500–509 (2016).
   PubMed Web of Science ®Google Scholar
• Kim YC , Guan KL . mTOR: a pharmacologic target for autophagy regulation. J. Clin. Invest. 125(1), 25–32 (2015).
   PubMed Web of Science ®Google Scholar
• Yang H , Zhou L , Shi Q et al. SIRT3-dependent GOT2 acetylation status affects the malate–aspartate NADH shuttle activity and pancreatic tumor growth. EMBO J. 34(8), 1110–1125 (2015).
   PubMed Web of Science ®Google Scholar
• Yang S , Hwang S , Kim M , Seo SB , Lee JH , Jeong SM . Mitochondrial glutamine metabolism via GOT2 supports pancreatic cancer growth through senescence inhibition. Cell Death Dis. 9(2), 55 (2018).
   PubMedGoogle Scholar
• Feist M , Schwarzfischer P , Heinrich P et al. Cooperative STAT/NF-kappaB signaling regulates lymphoma metabolic reprogramming and aberrant GOT2 expression. Nat. Commun. 9(1), 1514 (2018).
   PubMedGoogle Scholar
• Hong R , Zhang W , Xia X et al. Preventing BRCA1/ZBRK1 repressor complex binding to the GOT2 promoter results in accelerated aspartate biosynthesis and promotion of cell proliferation. Mol. Oncol. 13(4), 959–977 (2019).
   PubMed Web of Science ®Google Scholar
• Wang T , Yao W , Li J , He Q , Shao Y , Huang F . Acetyl-CoA from inflammation-induced fatty acids oxidation promotes hepatic malate–aspartate shuttle activity and glycolysis. Am. J. Physiol. Endocrinol. Metab. 315(4), E496–E510 (2018).
   PubMed Web of Science ®Google Scholar
• Rogers AB , Fox JG . Inflammation and cancer. I. Rodent models of infectious gastrointestinal and liver cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 286(3), G361–G366 (2004).
   PubMed Web of Science ®Google Scholar
• Bishayee A . The role of inflammation and liver cancer. Adv. Exp. Med. Biol. 816, 401–435 (2014).
   PubMed Web of Science ®Google Scholar
• Li XF , Chen C , Xiang DM et al. Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance. Hepatology 66(6), 1934–1951 (2017).
   PubMed Web of Science ®Google Scholar
• Islam MA , Sooro MA , Zhang P . Autophagic regulation of p62 is critical for cancer therapy. Int. J. Mol. Sci. 19(5), 1405 (2018).
   PubMed Web of Science ®Google Scholar
• Ichimura Y , Waguri S , Sou YS et al. Phosphorylation of p62 activates the Keap1–Nrf2 pathway during selective autophagy. Mol. Cell 51(5), 618–631 (2013).
   PubMed Web of Science ®Google Scholar
• Kabeya Y , Mizushima N , Yamamoto A , Oshitani-Okamoto S , Ohsumi Y , Yoshimori T . LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J. Cell Sci. 117(Pt 13), 2805–2812 (2004).
   PubMed Web of Science ®Google Scholar
• Kabeya Y , Mizushima N , Ueno T et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19(21), 5720–5728 (2000).
   PubMed Web of Science ®Google Scholar
• Ichimura Y , Kominami E , Tanaka K , Komatsu M . Selective turnover of p62/A170/SQSTM1 by autophagy. Autophagy 4(8), 1063–1066 (2008).
   PubMed Web of Science ®Google Scholar
• Liu GY , Sabatini DM . mTOR at the nexus of nutrition, growth, ageing and disease. Nat. Rev. Mol. Cell Biol. 21(4), 183–203 (2020).
   PubMed Web of Science ®Google Scholar
• Liu L , Das S , Losert W , Parent CA . mTORC2 regulates neutrophil chemotaxis in a cAMP- and RhoA-dependent fashion. Dev. Cell 19(6), 845–857 (2010).
   PubMed Web of Science ®Google Scholar
• Li W , Li Y , Siraj S et al. FUN14 domain-containing 1-mediated mitophagy suppresses hepatocarcinogenesis by inhibition of inflammasome activation in mice. Hepatology 69(2), 604–621 (2019).
   PubMed Web of Science ®Google Scholar
• Li TT , Zhu D , Mou T et al. IL-37 induces autophagy in hepatocellular carcinoma cells by inhibiting the PI3K/AKT/mTOR pathway. Mol. Immunol. 87, 132–140 (2017).
   PubMed Web of Science ®Google Scholar
• Zhou Y , Wu PW , Yuan XW , Li J , Shi XL . Interleukin-17A inhibits cell autophagy under starvation and promotes cell migration via TAB2/TAB3-p38 mitogen-activated protein kinase pathways in hepatocellular carcinoma. Eur. Rev. Med. Pharmacol. Sci. 20(2), 250–263 (2016).
   PubMed Web of Science ®Google Scholar
• Peng WX , Xiong EM , Ge L et al. Egr-1 promotes hypoxia-induced autophagy to enhance chemo-resistance of hepatocellular carcinoma cells. Exp. Cell Res. 340(1), 62–70 (2016).
   PubMed Web of Science ®Google Scholar
• Bellot G , Garcia-Medina R , Gounon P et al. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol. Cell. Biol. 29(10), 2570–2581 (2009).
   PubMed Web of Science ®Google Scholar